Core Viewpoint - Chewy's stock has experienced significant volatility, but the company has maintained revenue growth, positioning it as a potential value stock for investors [1][10]. Company Performance - Chewy has successfully differentiated itself from competitors like Amazon through superior customer service and competitive pricing, which contributed to its stock price surge during the pandemic [3]. - Despite the stock price decline in 2021, Chewy has continued to grow, expanding its business model to include veterinary telehealth services and pharmaceuticals for pets [4]. Financial Metrics - In the first nine months of fiscal 2025, Chewy reported revenue of $9.3 billion, an 8% increase year-over-year, while operating income rose to $212 million, a 74% increase from $122 million in the same period of fiscal 2024 [5]. - Analysts project revenue growth of 6% for the current fiscal year and 8% for fiscal 2027, which may exert downward pressure on valuation metrics if the stock remains stagnant [6]. Valuation Insights - Chewy's market capitalization stands at $12 billion, with a current price-to-sales (P/S) ratio of 0.9, down from a peak of 7 in 2021, indicating a significant drop in valuation [8]. - Although the price-to-earnings (P/E) ratio is 55, the forward P/E ratio of 17 suggests that the stock may be undervalued, especially given the company's ongoing financial improvements [9]. Investment Consideration - After a prolonged period of decline and stagnation, Chewy stock may be poised for recovery, making it an attractive investment opportunity before broader market recognition of its growth and low valuation [10][11].
Chewy Stock Is Quietly Becoming a Buy Again. Here's Why.